Elucidating the specific role of IKBIP in ESCC and its underlying molecular mechanism will provide valuable information for understanding the pathogenesis of ESCC and facilitating the development of molecular inhibitors targeting ESCC. This evidence concerns the gene IKBIP and esophageal squamous cell carcinoma.